Influence of Pharmaceutical Copayment on Emergency Hospital Admissions: A 1978–2018 Time Series Analysis in Spain
No studies have evaluated the influence of pharmaceutical copayment on hospital admission rates using time series analysis. Therefore, we aimed to analyze the relationship between hospital admission rates and the influence of the introduction of a pharmaceutical copayment system (PCS). In July 2012,...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-07-01
|
Series: | International Journal of Environmental Research and Public Health |
Subjects: | |
Online Access: | https://www.mdpi.com/1660-4601/18/15/8009 |
id |
doaj-d9970a32b21b4d40925704e69af15aaf |
---|---|
record_format |
Article |
spelling |
doaj-d9970a32b21b4d40925704e69af15aaf2021-08-06T15:23:27ZengMDPI AGInternational Journal of Environmental Research and Public Health1661-78271660-46012021-07-01188009800910.3390/ijerph18158009Influence of Pharmaceutical Copayment on Emergency Hospital Admissions: A 1978–2018 Time Series Analysis in SpainAntonio Palazón-Bru0Miriam Calvo-Pérez1Pilar Rico-Ferreira2María Anunciación Freire-Ballesta3Vicente Francisco Gil-Guillén4María de los Ángeles Carbonell-Torregrosa5Department of Clinical Medicine, Miguel Hernández University, 03550 Alicante, SpainPrimary Care Pharmacy Service, General University Hospital of Elda, 03600 Alicante, SpainPrimary Care Pharmacy Service, General University Hospital of Elda, 03600 Alicante, SpainPrimary Care Pharmacy Service, General University Hospital of Alicante, 03010 Alicante, SpainDepartment of Clinical Medicine, Miguel Hernández University, 03550 Alicante, SpainDepartment of Clinical Medicine, Miguel Hernández University, 03550 Alicante, SpainNo studies have evaluated the influence of pharmaceutical copayment on hospital admission rates using time series analysis. Therefore, we aimed to analyze the relationship between hospital admission rates and the influence of the introduction of a pharmaceutical copayment system (PCS). In July 2012, a PCS was implemented in Spain, and we designed a time series analysis (1978–2018) to assess its impact on emergency hospital admissions. Hospital admission rates were estimated between 1978 and 2018 each month using the Hospital Morbidity Survey in Spain (the number of urgent hospital admissions per 100,000 inhabitants). This was conducted for men, women and both and for all-cause, cardiovascular and respiratory hospital discharges. Life expectancy was obtained from the National Institute of Statistics. The copayment variable took a value of 0 before its implementation (pre-PCS: January 1978–June 2012) and 1 after that (post-PCS: July 2012–December 2018). ARIMA (Autoregressive Integrated Moving Average) (2,0,0)(1,0,0) models were estimated with two predictors (life expectancy and copayment implementation). Pharmaceutical copayment did not influence hospital admission rates (with <i>p</i>-values between 0.448 and 0.925) and there was even a reduction in the rates for most of the analyses performed. In conclusion, the PCS did not influence hospital admission rates. More studies are needed to design health policies that strike a balance between the amount contributed by the taxpayer and hospital admission rates.https://www.mdpi.com/1660-4601/18/15/8009pharmacycopaymenthealth expenditurescost controlhospitalizationinpatients |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Antonio Palazón-Bru Miriam Calvo-Pérez Pilar Rico-Ferreira María Anunciación Freire-Ballesta Vicente Francisco Gil-Guillén María de los Ángeles Carbonell-Torregrosa |
spellingShingle |
Antonio Palazón-Bru Miriam Calvo-Pérez Pilar Rico-Ferreira María Anunciación Freire-Ballesta Vicente Francisco Gil-Guillén María de los Ángeles Carbonell-Torregrosa Influence of Pharmaceutical Copayment on Emergency Hospital Admissions: A 1978–2018 Time Series Analysis in Spain International Journal of Environmental Research and Public Health pharmacy copayment health expenditures cost control hospitalization inpatients |
author_facet |
Antonio Palazón-Bru Miriam Calvo-Pérez Pilar Rico-Ferreira María Anunciación Freire-Ballesta Vicente Francisco Gil-Guillén María de los Ángeles Carbonell-Torregrosa |
author_sort |
Antonio Palazón-Bru |
title |
Influence of Pharmaceutical Copayment on Emergency Hospital Admissions: A 1978–2018 Time Series Analysis in Spain |
title_short |
Influence of Pharmaceutical Copayment on Emergency Hospital Admissions: A 1978–2018 Time Series Analysis in Spain |
title_full |
Influence of Pharmaceutical Copayment on Emergency Hospital Admissions: A 1978–2018 Time Series Analysis in Spain |
title_fullStr |
Influence of Pharmaceutical Copayment on Emergency Hospital Admissions: A 1978–2018 Time Series Analysis in Spain |
title_full_unstemmed |
Influence of Pharmaceutical Copayment on Emergency Hospital Admissions: A 1978–2018 Time Series Analysis in Spain |
title_sort |
influence of pharmaceutical copayment on emergency hospital admissions: a 1978–2018 time series analysis in spain |
publisher |
MDPI AG |
series |
International Journal of Environmental Research and Public Health |
issn |
1661-7827 1660-4601 |
publishDate |
2021-07-01 |
description |
No studies have evaluated the influence of pharmaceutical copayment on hospital admission rates using time series analysis. Therefore, we aimed to analyze the relationship between hospital admission rates and the influence of the introduction of a pharmaceutical copayment system (PCS). In July 2012, a PCS was implemented in Spain, and we designed a time series analysis (1978–2018) to assess its impact on emergency hospital admissions. Hospital admission rates were estimated between 1978 and 2018 each month using the Hospital Morbidity Survey in Spain (the number of urgent hospital admissions per 100,000 inhabitants). This was conducted for men, women and both and for all-cause, cardiovascular and respiratory hospital discharges. Life expectancy was obtained from the National Institute of Statistics. The copayment variable took a value of 0 before its implementation (pre-PCS: January 1978–June 2012) and 1 after that (post-PCS: July 2012–December 2018). ARIMA (Autoregressive Integrated Moving Average) (2,0,0)(1,0,0) models were estimated with two predictors (life expectancy and copayment implementation). Pharmaceutical copayment did not influence hospital admission rates (with <i>p</i>-values between 0.448 and 0.925) and there was even a reduction in the rates for most of the analyses performed. In conclusion, the PCS did not influence hospital admission rates. More studies are needed to design health policies that strike a balance between the amount contributed by the taxpayer and hospital admission rates. |
topic |
pharmacy copayment health expenditures cost control hospitalization inpatients |
url |
https://www.mdpi.com/1660-4601/18/15/8009 |
work_keys_str_mv |
AT antoniopalazonbru influenceofpharmaceuticalcopaymentonemergencyhospitaladmissionsa19782018timeseriesanalysisinspain AT miriamcalvoperez influenceofpharmaceuticalcopaymentonemergencyhospitaladmissionsa19782018timeseriesanalysisinspain AT pilarricoferreira influenceofpharmaceuticalcopaymentonemergencyhospitaladmissionsa19782018timeseriesanalysisinspain AT mariaanunciacionfreireballesta influenceofpharmaceuticalcopaymentonemergencyhospitaladmissionsa19782018timeseriesanalysisinspain AT vicentefranciscogilguillen influenceofpharmaceuticalcopaymentonemergencyhospitaladmissionsa19782018timeseriesanalysisinspain AT mariadelosangelescarbonelltorregrosa influenceofpharmaceuticalcopaymentonemergencyhospitaladmissionsa19782018timeseriesanalysisinspain |
_version_ |
1721218538422665216 |